Connect with us

Hi, what are you looking for?

Friday, May 27, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Annual sales up 136% to US$380.4M for Ascend Wellness

But fourth-quarter revenue lagged with a slowdown across its wholesale business

Annual Annual sales up 136% to US$380.4M for Ascend Wellness up 136% to US$380.4M for AWH
Photo via Ascend

It was a strong sales year overall for multistate operator Ascend Wellness Holdings, Inc. (CSE: AAWH.U) (OTCQX: AAWH), but momentum slowed in the fourth quarter as wholesale revenues lagged.

On Tuesday, the company reported its earnings results for the fiscal year and quarter ended Dec. 31, with annual revenue up 136 per cent to US$380.4 million from US$143.7 million.

But over the year, net loss quintupled to negative US$122.7 million from negative US$23.8 million the year before.

In the fourth quarter, sales dipped 6 per cent to US$88.5 million from US$94.4 million in the previous quarter. In the same period, gross profit fell 25 per cent to US$30.8 million from US$41 million.

Quarterly net loss rose by 27 per cent to negative US$16.5 million from negative US$13 million.

Fourth-quarter adjusted earnings before interest, taxes, depreciation and amortization fell 16 per cent to US$19.8 million from US$23.5 million.

At the end of the period, Ascend had US$155.5 million in cash and cash equivalents.

In a statement, the company says its quarterly revenue decline was driven by lower wholesale prices in Illinois, as well as lower wholesale volumes there and in Massachusetts. But it says those drops were partially offset by higher volumes in Michigan and New Jersey combined with more retail traffic.

Read more: Curaleaf posts record US$1.2B in sales for fiscal 2021

Read more: Tilray to buy US$211M in Hexo debt for equity ownership

Compared to the same quarter in 2020, net revenue was up 63 per cent, which Ascend says was due to the addition of eight new dispensaries, increased traffic at existing stores, more products sold in its wholesale business and 100,000 square feet of added growing space.

In the fourth quarter, sequential retail revenue was up 2 per cent to US$64.9 million, due to more traffic at existing stores as well as new store openings in Newton, Massachusetts, and Carroll, Ohio.

Operational costs for Ascend rose as it increased staffing at its facilities ahead of the growing space expansions.

2021 was a year marked by record sales and other milestones, founder and CEO Abner Kurtin said in the statement.

“We pursued an aggressive expansion plan, opening six stores, acquiring two stores, and adding 100,000 square feet of canopy, which enabled us to achieve annual revenue growth of more than 130 per cent,” he said. “Although competitive conditions arose in the fourth quarter, I remain confident in the longer term potential of the industry.”

“Q4 2021 through the first half of 2022 represent a bit of a pause for Ascend as we bring new assets online. As we enter 2022, we are working to optimize our asset base, improve our market positioning, and prepare for the highly-anticipated New Jersey adult-use market.”

Company stock traded flat Tuesday at US$4.00 on the Canadian Securities Exchange. Shares in Ascend have fallen almost 58 per cent from its highly anticipated initial public offering last May.


Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Nick Laba on Twitter

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can


As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices


Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance


While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe